for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Somnomed Limited

SOM.AX

Latest Trade

2.38AUD

Change

0.03(+1.28%)

Volume

2,852

Today's Range

2.38

 - 

2.39

52 Week Range

1.27

 - 

2.58

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
2.35
Open
2.39
Volume
2,852
3M AVG Volume
0.54
Today's High
2.39
Today's Low
2.38
52 Week High
2.58
52 Week Low
1.27
Shares Out (MIL)
84.00
Market Cap (MIL)
194.48
Forward P/E
95.92
Dividend (Yield %)
--

Next Event

Half Year 2022 Somnomed Ltd Earnings Release

Latest Developments

更多

Somnomed Qtrly Rev Rises 1%

Somnomed Says HY Revenue Fell 7%

Somnomed Posts Q1 Revenues Of $13.7 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Somnomed Limited

SomnoMed Limited is engaged in the business of producing and selling devices for the oral treatment of sleep related disorders primarily in the Asia Pacific region, North America and Europe. The Company's products include SomnoDent Fusion, SomnoDent Flex, SomnoDent Classic, Somnodent SUAD, Somnodent SUAD Ultra, SomnoDent Herbst Advance, SomnoDent AIR & AIR+ and Morning Repositioner. The SomnoDent Herbst Advance is an intraoral device featuring a visual calibration indicator for the treatment of obstructive sleep apnea (OSA). The Company manufactures custom fit acrylic occlusal splints (dental guards), the SomnoBrux, to protect patient's teeth against heaving grinding and bruxism. Its SomnoBrux products include Gelb, Tanner and Michigan. It offers SOMGauge, which is an autoclavable instrument that can be used to construct reliable bite records. The Company provides medical reimbursement services to assist dental offices with submitting a medical claim for their patients' OSA treatment.

Industry

Healthcare Facilities

Contact Info

L 3 20 Clarke St, Crows Nest

SYDNEY, NSW

2065

Australia

+61.2.94670400

https://www.somnomed.com.au/

Executive Leadership

Guy Russo

Non-Executive Chairman of the Board

Kien T. Nguyen

President - SomnoMed Inc.

Neil Robert Verdal-Austin

Chief Executive Officer, Managing Director

Herve Fievet

Chief Financial Officer

James R. Evanger

President, Chief Executive Officer of Sleep Centres America, Inc

Key Stats

3.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, AUD)

2018

0.1K

2019

0.1K

2020

0.1K

2021(E)

0.1K
EPS (AUD)

2018

-0.115

2020

-0.034

2021(E)

0.025
Price To Earnings (TTM)
--
Price To Sales (TTM)
3.54
Price To Book (MRQ)
5.87
Price To Cash Flow (TTM)
66.75
Total Debt To Equity (MRQ)
28.70
LT Debt To Equity (MRQ)
26.31
Return on Investment (TTM)
-1.88
Return on Equity (TTM)
-1.28

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up